S'abonner

Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny - 10/08/11

Doi : 10.1016/j.jaci.2010.09.020 
Meri K. Tulic, BSc, PhD a, , Megan Hodder, BSc a, Anna Forsberg, MSc b, Suzi McCarthy, BSc a, Tara Richman, BSc a, Nina D’Vaz, BSc a, Anita H.J. van den Biggelaar, BSc, PhD c, Catherine A. Thornton, BSc, PhD d, Susan L. Prescott, MD, PhD a
a Childhood Allergy and Immunology Research, School of Paediatrics and Child Health, University of Western Australia, Perth, Australia 
b Department of Clinical and Experimental Medicine, Division of Inflammation Medicine, Linköping University, Linkoping, Sweden 
c Division of Cell Biology, Telethon Institute for Child Health Research, Centre for Child Health Research, UWA, Perth, Australia 
d Institute of Life Science, School of Medicine, Swansea University, Swansea, United Kingdom 

Reprint requests: Meri K. Tulic, BSc, PhD, School of Paediatrics and Child Health, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth, Australia.

Abstract

Background

Microbial products are of central interest in the modulation of allergic propensity.

Objective

We sought to explore whether allergic children show differences in microbial Toll-like receptor (TLR)–mediated responses over their first 5 years of life.

Methods

Mononuclear cells isolated from 35 allergic and 35 nonallergic children at birth and 1, 2.5, and 5 years of age were stimulated with TLR2-TLR9 ligands to study innate immune function and with allergens or mitogen to assess adaptive T-cell responses. Cytokine production was measured by using Luminex multiplexing technology.

Results

Nonallergic children show progressive and significant age-related increases in innate cytokine responses (IL-1β, IL-6, TNF-⍺, and IL-10) to virtually all TLR ligands. This innate maturation corresponds with a parallel increase in adaptive TH1 (IFN-γ) responses to allergens and mitogens. In contrast, allergic children show exaggerated innate responses at birth (P < .01) but a relative decrease with age thereafter, so that by age 5 years, TLR responses are attenuated compared with those seen in nonallergic subjects (P < .05). This early hyperresponsiveness in allergic subjects fails to translate to a corresponding maturation of TH1 function, which remains attenuated relative to that seen in nonallergic subjects but is associated with a characteristic age-dependent increase in allergen-specific TH2 responses (P < .01).

Conclusion

Our findings suggest significant differences in the developmental trajectory of innate immune function in children with allergic disease that might contribute to the recognized differences in postnatal adaptive T-cell immunity.

Le texte complet de cet article est disponible en PDF.

Key words : Toll-like receptor, ontogeny, innate immunity, allergic disease, children

Abbreviations used : APC, mDC, NK, pDC, SPT, TLR


Plan


 Supported by the National Health and Medical Research Council (NHMRC) of Australia (grant ID 458502). S. L. P. is supported by an NHMRC Practitioner Fellowship, and M. K. T. is supported by an NHMRC Career Development Award.
 Disclosure of potential conflict of interest: M. K. Tulic receives research support from the National Health and Medical Research Council (NHMRC), Australia. C. A. Thornton has received research support from the Welsh Office of Research and Development. S. L. Prescott is on the advisory board for Nestle Nutrition, is a consultant for Fonterra, is a speaker for Nutricia, and receives research support from the National Health and Medical Research Council (NHMRC), Australia. The rest of the authors have declared that they have no conflict of interest.


© 2010  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 127 - N° 2

P. 470 - février 2011 Retour au numéro
Article précédent Article précédent
  • Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs
  • Elad H. Kaufman, Allison D. Fryer, David B. Jacoby
| Article suivant Article suivant
  • Structural and immunologic cross-reactivity among filarial and mite tropomyosin: Implications for the hygiene hypothesis
  • Helton C. Santiago, Sasisekhar Bennuru, Alexis Boyd, Mark Eberhard, Thomas B. Nutman

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.